Arunachalam Muthuraman

Dr. Arunachalam Muthuraman

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Pharmacological Reports
Verified
Journal Article
Closed access
ASAmrit Pal Singh
Amrit Pal Singh
AMArunachalam Muthuraman
Arunachalam Muthuraman
AJAmteshwar Singh Jaggi
Amteshwar Singh Jaggi
NSNirmal Singh
Nirmal Singh
KGKuldeep Grover
Kuldeep Grover
RDRavi Dhawan
Ravi Dhawan

1 April 2018 in Life Sciences
Verified
Journal Article
Closed access
NRNarahari Rishitha
Narahari Rishitha
AMArunachalam Muthuraman
Arunachalam Muthuraman

1 June 2008 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AMArunachalam Muthuraman
Arunachalam Muthuraman
AJAmteshwar Singh Jaggi
Amteshwar Singh Jaggi
NSNirmal Singh
Nirmal Singh
DSDhandeep Singh
Dhandeep Singh

22 March 2011 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
AMArunachalam Muthuraman
Arunachalam Muthuraman
NSNirmal Singh
Nirmal Singh
Acorus calamus (family: Araceae), is an indigenous plant, traditionally it is used as an ingredient of various cocktail preparations and for the management of severe inflammatory disorders in Indian system of medicine. Present study investigated the attenuating role of Acorus calamus plant extract in chronic constriction injury (CCI) of sciatic nerve induced peripheral neuropathy in rats.

1 October 2011 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AMArunachalam Muthuraman
Arunachalam Muthuraman
NSNirmal Singh
Nirmal Singh
AJAmteshwar Singh Jaggi
Amteshwar Singh Jaggi

2 July 2010 in Inflammopharmacology
Verified
Journal Article
Open access
PDF file
AMArunachalam Muthuraman
Arunachalam Muthuraman
SSShailja Sood
Shailja Sood
SSSumeet Kumar Singla
Sumeet Kumar Singla
Antiinflammatory effects of phenolic compounds from Emblica officinalis were evaluated in carrageenan and cotton pellet induced acute and chronic inflammatory animal model. Fractions of E. officinalis containing free (FPEO) and bounded (BPEO) phenolic compounds were assessed by HPLC technique. The free and bound phenolic compounds were studied for their acute and chronic antiinflammatory activity at dose level of 20 and 40 mg/kg. The carrageenan induced acute inflammation was assessed by measuring rat paw volume at different time of intervals. Further, cotton pellet induced chronic inflammation was assessed by granulomatous tissue mass estimation along with the estimation of tissue biomarker changes (i.e. lipid peroxidation, reduced glutathione, myeloperoxidase and plasma extravasation). The results indicated that in both acute and chronic inflammation, FPEO and BPEO show reduction in the inflammation, but significant effects was observed only at high doses of both fractions which was comparable to diclofenac treated group. In conclusion, phenolic compounds of E. officinalis may serve as potential herbal candidate for amelioration of acute and chronic inflammation due to their modulatory action of free radicals.